HawaiiSB 27512025–2026 Regular Session (Year 2)Senate

RELATING TO WORKERS' COMPENSATION.

Sponsored By: Jr. Ihara (Democratic)

Passed

Summary

Defines compounded prescription drugs for the purposes of the State's Workers' Compensation Law. Limits dispensing of prescription drugs by physician to 30 days after the industrial injury and requires all prescription drugs to be obtained through the employer's pharmacy benefit manager thereafter. Requires prescription drugs not approved by the Food and Drug Administration (FDA), such as compounds, to be identified as compounds when listed on the treatment plan and when billed, and be supported by a statement of medical necessity documenting the case of medical need for a compound drug over an FDA-approved over-the-counter or prescription drug of similar therapeutic effect. Effective 1/1/2077. (SD1)

Workers' CompensationBenefitsPrescription DrugsCompounded Prescription DrugsPhysician Dispensing TimeframeNon-FDA-Approved DrugsIdentificationStatement of Medical NecessityLBT/HHS, JDC

Your PRIA Score

Score Hidden

Personalized for You

How does this bill affect your finances?

Sign up for a PRIA Policy Scan to see your personalized alignment score for this bill and every other piece of legislation we track. We analyze your financial profile against policy provisions to show you exactly what matters to your wallet.

Free to start

Bill Overview

No Economic Impacts Identified for this Bill

Sponsors & Cosponsors

Sponsor

  • Jr. Ihara

    Democratic • Senate

Cosponsors

There are no cosponsors for this bill.

Roll Call Votes

All Roll Calls

Yes: 9 • No: 0

Senate vote 2/4/2026

The committee(s) on LBT recommend(s) that the measure be PASSED, WITH AMENDMENT...

Yes: 4 • No: 0

Senate vote 2/4/2026

The committee(s) on HHS recommend(s) that the measure be PASSED, WITH AMENDMENT...

Yes: 5 • No: 0

Actions Timeline

  1. The committee on JDC deferred the measure.

    3/3/2026Senate
  2. The committee(s) on JDC will hold a public decision making on 03-03-26 10:15AM; Conference Room 016 & Videoconference.

    2/24/2026Senate
  3. Reported from LBT/HHS (Stand. Com. Rep. No. 2217) with recommendation of passage on Second Reading, as amended (SD 1) and referral to JDC.

    2/12/2026Senate
  4. Report adopted; Passed Second Reading, as amended (SD 1) and referred to JDC.

    2/12/2026Senate
  5. The committee(s) on LBT recommend(s) that the measure be PASSED, WITH AMENDMENTS. The votes in LBT were as follows: 4 Aye(s): Senator(s) Elefante, Lamosao, Moriwaki, Fevella; Aye(s) with reservations: none ; 0 No(es): none; and 1 Excused: Senator(s) Ihara.

    2/4/2026Senate
  6. The committee(s) on HHS recommend(s) that the measure be PASSED, WITH AMENDMENTS. The votes in HHS were as follows: 5 Aye(s): Senator(s) San Buenaventura, McKelvey, Kanuha, Keohokalole, Fevella; Aye(s) with reservations: none ; 0 No(es): none; and 0 Excused: none.

    2/4/2026Senate
  7. Referred to LBT/HHS, JDC.

    1/30/2026Senate
  8. The committee(s) on LBT/HHS has scheduled a public hearing on 02-04-26 1:00PM; Conference Room 225 & Videoconference.

    1/30/2026Senate
  9. Passed First Reading.

    1/26/2026Senate
  10. Introduced.

    1/23/2026Senate

Bill Text

Related Bills

Back to State Legislation